目錄:杭州斯達特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B060Anti-CD49d Monoclonal Antibody(Natalizumab)
Natalizumab, is a monoclonal antibody which targets a protein called α4β1 integrin on white blood cells involved in inflammation. By attaching to integrin, natalizumab is thought to stop white blood cells from entering the brain and spinal cord tissue, thereby reducing inflammation and the resulting nerve damage.
1
化工儀器網